Introduction: Surgery is the only potential for cure in patients with pancreatic neuroendocrine tumors (pNETs).
Aim(s): To describe the neoadjuvant use of [177Lu-DOTA0,Tyr3]octreotate (177Lu-octreotate) in nonfunctioning pNETs.
Materials and methods: We studied 119 Dutch patients with a nonfunctioning pNET treated with 177Lu-octreotate. Patients were divided into three groups: locally advanced tumor (group 1); ≤3 liver metastases (group 2); >3 liver metastases/other distant metastases (group 3). Patients in group 1+2 were considered neoadjuvant treated patients.
Conference: 10th Annual ENETS Conference 2013 (2013)
Category: Surgical treatment
Presenting Author: Esther I Van Vliet
Van Vliet E I
, Van Eijck C
, De Krijger R R
, Nieveen van Dijkum E J
, Teunissen J J
, Kam B L
, De Herder W
, Feelders R
, Bonsing B A
, Krenning E P
, Kwekkeboom D J
To read results and conclusion, please login ...
Further abstracts you may be interested in